Page last updated: 2024-10-29

jl 18 and Dyskinesia, Drug-Induced

jl 18 has been researched along with Dyskinesia, Drug-Induced in 1 studies

JL 18: a pyridobenzodiazepine derivative bioisoster of clozapine

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hadj Tahar, A1
Bélanger, N1
Bangassoro, E1
Grégoire, L1
Bédard, PJ1

Other Studies

1 other study available for jl 18 and Dyskinesia, Drug-Induced

ArticleYear
Antidyskinetic effect of JL-18, a clozapine analog, in parkinsonian monkeys.
    European journal of pharmacology, 2000, Jul-07, Volume: 399, Issue:2-3

    Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Benserazide; Clozapine; Dose-

2000